Drug Database
CE
cefaclor (Raniclor / Raniclor)
✓ ApprovedRanbaxy Laboratories Limited · Small Molecule · Small Molecule
What is cefaclor?
cefaclor is a small molecule developed by Ranbaxy Laboratories Limited. It is approved for therapeutic indications via oral (po).
Drug Profile
| Brand Names | Raniclor, Raniclor |
| Company | Ranbaxy Laboratories Limited |
| Drug Class | Small Molecule |
| Route | Oral (PO) |
| Status | Approved |
Therapeutic Indications
cefaclor is developed for 6 unique indications across 3 therapeutic areas.
| Therapeutic Area | Condition | Phase |
|---|---|---|
| Infections and infestations | Lower respiratory tract infection | ✓ Approved |
| Infections and infestations | Otitis media | ✓ Approved |
| Infections and infestations | Tonsillitis | ✓ Approved |
| Infections and infestations | Urinary tract infection | ✓ Approved |
| Respiratory, thoracic and mediastinal disorders | Tonsillar inflammation | ✓ Approved |
+1 more indication available with a free account
Sign up free to view all indications →Related Research Articles
Unable to load articles right now.